Advanced search×

[Bioequivalence of anvifen and phenibut].

A V AV Zhezlova, V G VG Belolipetskaia, S V SV Blagodatskikh, and E V EV Merkulova

Eksp Klin Farmakol 74(5):43-4 (2011) PMID 21809698

An open randomized crossover test on 18 healthy volunteers was used to study the pharmacokinetics of anvifen (acting substance, aminophenylbutyric acid) manufactured in capsules at the Joint-Stock Company "Antiviral" (Russia). The test was performed after single peroral administration in comparison with phenibut tablets of the same manufacturer. The concentration of unchanged aminophenylbutiric acid in the blood plasma was measured by HPLC with UV detection. It is established that anvifen and phenibut are bioequivalent in terms of pharmacokinetics.

Version: za2963e q8za9 q8zb0 q8zc4 q8zde q8zef q8zf5 q8zg3
Buy PDF

Similar articles you may find interesting…

  1. Relative bioavailability of two formulations of nevirapine 200-mg tablets in healthy Chinese male volunteers: A single-dose, randomized-sequ...
    Yubing Zhu, Qian Zhang, and Yunfang Hu

    Clin Ther 32(13):7 (2010) PMID 21316541

    In this single-dose study in healthy fasted Chinese males, the test tablet met the regulatory criterion for assumption of bioequivalence to the reference tablet. Both formulations were well tolerated in the population studied. SFDA registration no: 2009L04358. Copyright © 2010 Elsev...
    Buy PDF
  2. Single-dose bioequivalence assessment of two formulations of polysaccharide iron complex capsules in healthy adult male Chinese volunteers: ...
    Zhang, Liu, and Li

    Curr Ther Res Clin Exp 70(2):12 (2009)

    Buy PDF
  3. Establishing Pharmacokinetic Bioequivalence of Valganciclovir Oral Solution Versus the Tablet Formulation
    M D MD Pescovitz, A A Jain, and M R MR Bouw

    Transplant Proc 39(10):6 (2007) PMID 18089334

    Dosing with valganciclovir tablets may not be appropriate in some patients, such as those on hemodialysis or children. A "tutti-frutti" flavored oral valganciclovir solution has been developed to provide flexibility in dosage needed to accommodate these patients. An adult, multicenter, open-label ra...
    Buy PDF